March 2006

Another milestone for Onconase

Alfacell Corp., the New Jersey pharmaceutical company, got enough patients to go ahead with phase IIIb testing on Onconase, (ranpirnase). Another step in the long process toward getting approval for that drug, which is promising in mesothelioma treatment. The drug companies sometimes target mesothelioma in their development process even though it is a rare form […]

Another milestone for Onconase Read More »

B-reader consistency?

Impact Analysis blog talks about the integrity of B Readers as expert witnesses in occupational health court cases. NIOSH B Reader approval is granted to physicians who demonstrate proficiency in the classification of chest radiographs for the pneumoconioses using the International Labour Office (ILO) Classification System. Mesothelioma Aid’s write-up on B-readers is here. This is

B-reader consistency? Read More »